Filing Details

Accession Number:
0001144204-15-015396
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-11 16:49:44
Reporting Period:
2015-03-09
Filing Date:
2015-03-11
Accepted Time:
2015-03-11 16:49:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1433607 Inspiremd Inc. NSPR Surgical & Medical Instruments & Apparatus (3841) 262123838
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1528577 Paul Stuka C/O Osiris Partners, Llc
One Liberty Square, 5Th Floor
Boston MA 02109
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-09 625,000 $0.00 1,370,204 No 4 P Indirect See Note
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Note
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (right to buy) Acquisiton 2015-03-09 625,000 $0.00 625,000 $0.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
625,000 2015-03-09 2020-03-09 No 4 P Indirect
Footnotes
  1. In connection with the public offering, on March 9, 2015 (the "Offering"), the reporting person purchased 625,000 shares of common stock and warrants to purchase 625,000 shares of common stock.
  2. The purchase price for the reported securities was $0.40 per share of common stock and accompanying warrant to purchase one share of common stock, which were purchased together in the Offering.
  3. These securities are held by Osiris Investment Partners, L.P. ("Osiris"). Mr. Stuka serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, Mr. Stuka may be deemed to beneficially own the reported securities. Mr. Stuka disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes.